BPC-157
BPC-157 is a synthetic 15-amino acid peptide derived from a protective protein in human gastric juice. It's one of the most extensively researched peptides for healing and tissue repair.
MECHANISM OF ACTION
BPC-157 works by promoting angiogenesis (new blood vessel formation), enhancing collagen synthesis, and modulating growth factors. It's remarkably stable in stomach acid, making it effective both orally and via injection. It reduces inflammation without suppressing the immune system.
POTENTIAL BENEFITS
Accelerated healing of tendons, ligaments, muscles, and bones
Gastric protection and ulcer prevention
Reduced inflammation and pain
Neuroprotection and spinal cord injury recovery
Systemic healing effects throughout the body
Improved digestive comfort and GI repair
WHY IT'S BEING RESEARCHED
BPC-157 addresses a critical gap in healing — most compounds either suppress inflammation or stimulate growth, but BPC-157 does both while promoting healthy tissue regeneration. Its dual oral and injectable bioavailability makes it unique for both localized and systemic applications.
INTERESTING FACTS
Prohibited by WADA (2022) for athletes — no therapeutic use exemption available
Works synergistically with TB-500, Ipamorelin, and CJC-1295 for enhanced healing
Oral form is stable in gastric acid and requires no refrigeration
Injectable form shows results within 1-2 weeks for inflammation, 4-8 weeks for maximum tissue repair
Dosing ranges from 250-500mcg injectable (1-2x daily) to 500mcg-2mg oral (1-2x daily)
Expected timeline: pain reduction week 1-2, visible healing week 2-4, maximum benefits week 4-8
RESEARCH PURPOSES ONLY
NOT AVAILABLE FOR HUMAN CONSUMPTION

